Curated News
By: NewsRamp Editorial Staff
June 30, 2026

SS Innovations Wins Outstanding Company at 2026 Surgical Robotics Awards

Discuss on Telegram View History of this news story on GitHub
Original Source

TLDR

  • SS Innovations won Outstanding Company award, signaling its SSi Mantra system's growing commercial success and leadership in surgical robotics.
  • The SSi Mantra system has performed 11,719 procedures across 170 types, with 2,100 trained physicians and approval in 14 countries.
  • SS Innovations aims to make robotic surgery affordable and accessible globally, with telesurgeries and pediatric procedures improving healthcare equity.
  • The SSi Mantra system enabled 175 telesurgeries and 212 pediatric surgeries, showcasing its versatility and reach in remote care.

Impact - Why it Matters

This news matters because SS Innovations' award and the rapid adoption of its SSi Mantra system signal a shift toward more affordable and accessible robotic surgery. With over 11,700 procedures performed and regulatory approval in 14 countries, the system is poised to expand globally, potentially reducing costs and improving surgical outcomes for patients worldwide. For investors, the company's growing traction and recognition highlight its potential in the competitive surgical robotics market.

Summary

SS Innovations International (NASDAQ: SSII), a leader in surgical robotics, has been awarded the Outstanding Company title at the 2026 Surgical Robotics Industry Awards. The accolade recognizes the company's excellence in innovation, commercial success, industry leadership, and positive societal impact. This award underscores the growing adoption of its SS Innovations International (NASDAQ: SSII) SSi Mantra surgical robotic system, which is gaining traction for its advanced technology, user-friendly design, comprehensive training capabilities, and cost efficiency. The system is designed to make robotic surgery more affordable and accessible globally, aligning with the company's mission to democratize advanced surgical care.

As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the SSi Mantra system, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. The system has also been used for over 170 procedure types, with approximately 2,100 physicians trained on the platform. Regulatory approvals have been secured in 14 countries, highlighting the system's global reach and acceptance. The company's product range includes the SSi Mantra system and the SSi Mudra surgical instruments, supporting a variety of procedures, notably in cardiac surgery. Headquartered in India but incorporated in the U.S., SS Innovations plans to expand its global footprint with these cost-effective and user-friendly solutions.

The full press release is available at https://ibn.fm/XWdRe. SS Innovations continues to drive innovation in surgical robotics, aiming to bring the benefits of robotic surgery to a larger segment of the global population. For more information, visit the company's website at ssinnovations.com. TechMediaWire, a specialized communications platform, covered this announcement as part of its focus on pioneering technology companies. TechMediaWire is one of over 75 brands within the Dynamic Brand Portfolio @ IBN, delivering comprehensive corporate communications solutions.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Wins Outstanding Company at 2026 Surgical Robotics Awards

blockchain registration record for this content.